3,678
Total Claims
$446K
Drug Cost
326
Beneficiaries
$1,369
Cost/Patient
Peer Comparison vs. 110,156 Internal Medicine providers
-3%
Cost per patient vs peers
$1,369 vs $1,411 avg
+29%
Brand preference vs peers
13.7% vs 10.6% avg
Brand vs Generic
86% generic
Brand: 497 claims · $321K
Generic: 3,118 claims · $123K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 38 | $52K |
| Sitagliptin Phosphate | 34 | $35K |
| Dulaglutide | 19 | $33K |
| Apixaban | 37 | $32K |
| Empagliflozin | 30 | $31K |
| Rivaroxaban | 22 | $20K |
| Icosapent Ethyl | 27 | $17K |
| Sacubitril/Valsartan | 15 | $15K |
| Linaclotide | 11 | $11K |
| Insulin Glargine,hum.Rec.Anlog | 18 | $9,577 |
| Budesonide/Formoterol Fumarate | 21 | $9,346 |
| Nifedipine | 161 | $8,272 |
| Insulin Detemir | 18 | $6,551 |
| Atorvastatin Calcium | 288 | $5,412 |
| Losartan/Hydrochlorothiazide | 86 | $3,744 |
Prescribing Profile
Patient Profile
73
Avg Age
75%
Female
1.71
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data